Skip to main content
. 2018 Jun 26;9(49):29036–29046. doi: 10.18632/oncotarget.25528

Table 2. Select differentially-expressed genes in recurrent GBM.

Upregulated in recurrence
Gene name Gene symbol Relative expression P-value
transferrin TF 5.34 0.0085
interferon-induced protein with tetratricopeptide repeats 2 IFIT2 3.54 0.0006
apoptosis-associated tyrosine kinase AATK 3.38 0.0125
cyclin-dependent kinase 18 CDK18 3.30 0.0292
breast carcinoma amplified sequence 1 BCAS1 2.94 0.0221
microtubule-associated protein 7 MAP7 2.59 0.0101
fibroblast growth factor receptor 2 FGFR2 2.42 0.0400
ferritin, light polypeptide FTL 2.35 0.0025
fibroblast growth factor 1 FGF1 2.22 0.0058
signal transducer and activator of transcription 1 STAT1 2.08 0.0019
lysosomal-associated membrane protein 2 LAMP2 1.78 0.0008
Downregulated in recurrence
Gene name Gene symbol Relative expression P-value
neurocan NCAN 0.26 0.0433
glutamate receptor, ionotropic, AMPA 2 GRIA2 0.45 0.0334
fatty acid binding protein 7, brain FABP7 0.48 0.0236
ets variant 1 ETV1 0.49 0.0209
nestin NES 0.52 0.0370
TNF receptor-associated factor 4 TRAF4 0.53 0.0334
melanoma antigen family D, 4 MAGED4 0.54 0.0076
neuro-oncological ventral antigen 1 NOVA1 0.55 0.0330

P-values calculated using a two-sided Student’s T-Test